A Randomized, Double-Blind, Phase III Trial of Neoadjuvant Chemotherapy (NACT) with atezolizumab/Placebo in Patients with Triple-Negative Breast Cancer (TNBC) Followed by Adjuvant Continuation of atezolizumab/Placebo (Gepardouze) - Loibl, Sibylle; Jackisch, Christian; Seiler, Sabine; Rastogi, Priya; Huober, Lens; Denkert, Carsten; Schneeweiss, Andreas; Hanusch, Claus; Fasching, Peter; Blohmer, Jens-Uwe; Untch, Michael; Rhiem, Kerstin; et al. (ONCOLOGY RESEARCH AND TREATMENT, 2020)
CRIS-Team WoS Importer:2020-03-20